syncytial


Also found in: Dictionary, Thesaurus, Encyclopedia, Wikipedia.
Related to syncytial: respiratory syncytial virus

syn·cy·tial

(sin-si'shăl, -sish'ē-ăl, -sit'ē-ăl),
Relating to a syncytium.

syn·cy·tial

(sin-sish'ăl)
Relating to a syncytium.
References in periodicals archive ?
Respiratory syncytial virus (RSV) is a highly prevalent, very contagious respiratory infection and a leading cause of bronchitis and pneumonia, affecting more than 64 million people each year worldwide.1 Because the symptoms of RSV can be difficult to distinguish from influenza or other respiratory infections, many who are infected with RSV may not be properly diagnosed.
Respiratory Syncytial Virus (RSV) Therapeutics Market, by Dosage Form
"It also suggests that addressing this burden of respiratory syncytial virus, ideally through a future vaccine, could be a means of further reducing the occurrence of severe illness and death among children."
Extrapulmonary manifestations of severe respiratory syncytial virus infection: A systematic review.
The slides were studied under light microscope for identification of syncytial knots, fibrinoid necrosis, stromal fibrosis, congestion and calcification per low power field 10x objective for general architecture and 40x objective for further (conformed fibrosis, calcification and congestions in the slide of abruption placenta).
(4.) Shi T, McAllister DA, O'Brien KL, Simoes EAF, Madhi SA, Gessner BD, et al.; Respiratory Syncytial Virus Global Epidemiology Network.
Survey of diagnostic testing for respiratory syncytial virus (RSV) in adults: infectious disease physician practices and implications for burden estimates.
Respiratory syncytial virus outbreaks of epidemic levels occur yearly at predictable times.
Respiratory syncytial virus leads to approximately 3,400,000 hospital admissions and at least 66,000 deaths each year and 99% of these deaths occur in developing countries (4).
In a study of 395 otherwise healthy premature infants who were randomized to receive palivizumab for respiratory syncytial virus (RSV) immunoprophylaxis or placebo and followed for 6 years, 14% of the 199 infants in the RSV prevention group had parent-reported asthma, compared with 24% of the 196 in the placebo group (absolute risk reduction, 9.9%).
He said that syncytial virus , long recognized as the major viral pathogen of the lower respiratory tract of infants, has also been implicated in severe lung disease in child and adults, especially the elderly.
Respiratory viruses such as adenovirus, rhinovirus, respiratory syncytial virus, parainfluenza virus, human bocavirus, human metapneumovirus, and coronavirus were not detected in the nasopharyngeal swab specimen by multiplex PCR.